查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2005690

生物防御市场规模、份额、成长及全球产业分析：按类型和应用划分，区域洞察及2026-2034年预测

Biodefense Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 请询问到货日

价格

生物防御市场的成长要素

全球生物防御市场预计在2025年达到162.3亿美元，2026年成长至177.5亿美元，并在2034年达到268.8亿美元，预测期内复合年增长率（CAGR）为5.32%。 2025年，北美将以42.97%的市占率引领全球市场，这主要得益于政府的大力投资、先进的医疗基础设施以及生物技术和製药公司的积极参与。

生物防御是指旨在保护人类、生态系统和国家安全免受生物威胁的综合战略、技术和政策体系。这些威胁可能源自于自然发生的疫情、意外洩漏或蓄意的生物攻击。生物防御工作通常包括疫苗研发、病原体检测系统、生物监测和紧急应变准备。日益增长的流行病、生物恐怖主义和新兴感染疾病风险是推动该领域投资加速的主要动力。

俄乌衝突的影响

持续不断的俄乌衝突加剧了全球对非对称战争风险（包括生物製剂的使用）的认识。这种地缘政治情势促使各国政府和国防机构加强生物防御能力，并大幅增加对生物监测、快速诊断和医疗对策的投资。

此外，这场战争暴露了医疗卫生系统和供应链的脆弱性，促使各国加强疫苗和防护设备的国内生产。许多国家正在增加对病原体检测技术和生物安全基础设施研究的投入。因此，这场衝突间接地加速了国防费用，尤其是在北美和欧洲，因为各国政府都将重点放在应对疫情和加强国家安全上。

市场动态

市场驱动因素

人们越来越意识到生物风险

人们对生物威胁的日益关注，以及各国政府的积极倡议，正在推动生物防御市场的成长。世界各国政府都在大力投资疫苗储备、病原体检测系统和先进的生物监测技术。例如，2025年4月，帕森斯公司从美国海军医学研究司令部获得了一份价值2400万美元的合同，用于改进感染疾病检测调查。

人工智慧 (AI)、机器学习、物联网生物感测器和快速诊断等技术创新正在提高生物威胁侦测的速度和准确性。此外，一些突破性研究，例如密苏里大学于 2023 年开发的奈米孔生物感测器，正在提升生物感测器在疾病早期检测方面的性能。

市场限制因素

高昂的开发成本和监管挑战

儘管需求强劲，生物防御市场仍面临许多挑战。开发针对生物威胁的疫苗、诊断方法和治疗方案需要大量的研究、临床试验和监管核准，导致研发成本非常高。

许多生物防御产品针对罕见疾病，这使得进行大规模临床试验或证明其有效性变得困难。此外，严格的监管要求和法律责任风险也阻碍了一些公司投资该领域。如果没有政府采购合约的保障，公司可能难以收回研发成本。

市场机会

生物威胁日益加剧和技术进步

感染疾病爆发和疫情的威胁日益加剧，同时也带来了巨大的发展机会。新冠肺炎疫情凸显了快速检测系统和可扩展疫苗生产平台的重要性。

人工智慧驱动的生物监测、基于物联网的生物感测器和基因测序工具等新兴技术，为早期发现和应对生物威胁创造了新的机会。此外，政府、研究机构和私人公司之间的合作正在加速创新，并加强全球应对生物威胁的准备。

生物防御市场趋势

先进技术的融合

技术创新正在改变生物防御能力。人工智慧（AI）和机器学习正越来越多地应用于病原体识别、疫情预测和风险评估。

例如，2022 年，Tesseragen Biotechnology 与 Biomade 合作开发了一个人工智慧驱动的资料平台，以支援基于发酵的生物製造和应对生物威胁。

此外，生物技术和基因工程的进步正在推动新型疫苗平台、快速诊断测试和先进灭菌技术的研发。这些创新可望加强全球生物防御基础设施，并提高应对未来生物突发事件的准备能力。

細項分析

透过技术

以技术类别来看，市场包括紫外线、伽马射线、冷等离子体和微波加热。

预计到2025年，紫外线（UV）消毒领域将占据最大的市场份额，并成为成长最快的领域。紫外线技术因其能有效灭活细菌、病毒和真菌等微生物而被广泛用于消毒和杀菌。新冠疫情后，人们生物安全意识的提高以及对消毒技术需求的成长，正在推动其发展。

系统特定

市场可分为数位生物监测网路、预警系统、生物危害侦测系统、人工智慧辅助监测系统、生物感测器等。

由于生物危害检测系统在快速识别生物威胁方面发挥至关重要的作用，预计到2026年，该细分市场将占据35.19%的市场份额。同时，受携带式、高灵敏度病原体检测设备需求不断增长的推动，生物感测器细分市场预计将实现最快成长。

最终用户

市场细分包括军队、国防安全保障、医院和诊所、製药和生物技术公司以及病毒学研究机构。

预计到 2026 年，军工领域将主导市场，占 36.61% 的市场。这是因为军方需要先进的防护装备、疫苗和侦测系统来保护其人员免受生物威胁。

由于对疫苗研发、治疗和诊断技术的投资增加，预计製药和生技公司板块将成长最快。

区域展望

北美洲

预计2025年，北美将引领生物防御市场，规模达69.7亿美元。美国凭藉强有力的政府主导倡议和计画（例如「生物盾牌计划」和「生物医学高级研究与发展局」）在区域市场中处于领先地位。预计到2026年，美国市场规模将达到74.1亿美元。

欧洲

由于各国政府加大对生物安全和调查计画的投入，预计欧洲将成为成长最快的区域市场。英国和德国等国正大力投资生物防御技术，预计2026年，市场规模将分别达到7.1亿美元和6.2亿美元。

亚太地区

亚太地区正经历强劲成长，这主要得益于公众对健康问题的日益关注以及对疾病监测系统投资的不断增加。预计2026年，该地区市场规模将分别达到：中国34.8亿美元、印度6.5亿美元和日本4.4亿美元。

中东、非洲和拉丁美洲

由于人们对生物威胁的认识不断提高、政府主导的倡议以及生物技术研究活动的扩大，预计这些地区将经历适度增长。

儘管面临研发成本高和监管复杂等挑战，但全球应对生物威胁的准备工作不断加强，将继续推动对疫苗、检测系统和生物监测技术的需求。预计北美将继续保持主导地位，但欧洲和亚太地区将在未来十年成为主要的成长区域。

按细分市场和技术划分

  • 紫外线
  • 伽玛射线
  • 低温等离子体
  • 微波加热
  • 其他的

系统特定

  • 数位生物监测网络
  • 预警系统
  • 生物危害检测系统
  • 人工智慧监控系统
  • 生物感测器
  • 其他的

最终用户

  • 军队
  • 国防安全保障
  • 医院和诊所
  • 製药和生物技术公司
  • 病毒学研究所

按地区

  • 北美（按技术、系统、最终用户和国家划分）
    • 美国（最终用户）
    • 加拿大（最终用户）
  • 欧洲（按技术、系统、最终用户和国家划分）
    • 英国（最终用户）
    • 德国（最终用户）
    • 法国（最终用户）
    • 俄罗斯（最终用户）
    • 其他欧洲国家（按最终用户划分）
  • 亚太地区（按技术、系统、最终用户和国家划分）
    • 中国（最终用户）
    • 印度（最终用户）
    • 日本（最终用户）
    • 韩国（最终用户）
    • 其他亚太地区（按最终用户划分）
  • 中东和非洲（按技术、系统、最终用户和国家划分）
  • 伊朗（最终用户）
    • 以色列（最终用户）
    • 沙乌地阿拉伯（最终用户）
    • 土耳其（最终用户）
    • 其他中东和非洲地区（按最终用户划分）
  • 拉丁美洲（按技术、系统、最终用户和国家划分）
    • 巴西（最终用户）
    • 阿根廷（最终用户）
    • 墨西哥（最终用户）
    • 其他拉丁美洲国家（按最终用户划分）

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 产业主要趋势：重大合约和协议、合併、收购和合作。
  • 最新技术进展
  • 波特五力分析
  • 供应链分析
  • 定性分析－新冠疫情的影响：全球生物防御市场
  • 监管分析：全球生物防御市场

第五章：全球生物防御市场分析、洞察与预测（2021-2034年）

  • 主要发现和定义
  • 市场分析、洞察与预测：按技术划分
    • 微波加热
    • 紫外线
    • 伽玛射线
    • 冷等离子
    • 其他的
  • 市场分析、洞察与预测：按系统划分
    • 数位生物监测网络
    • 预警系统
    • 生物危害检测系统
    • 人工智慧辅助监控系统
    • 生物感测器
    • 其他的
  • 市场分析、洞察与预测：按最终用户划分
    • 军队
    • 国防安全保障
    • 医院和诊所
    • 製药和生物技术公司
    • 病毒学研究所
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 中东和非洲
    • 拉丁美洲

第六章：北美生物防御市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲生物防御市场分析、洞察与预测（2021-2034年）

  • 国家
    • 英国
    • 德国
    • 法国
    • 俄罗斯
    • 其他欧洲国家

第八章：亚太生物防御市场分析、洞察与预测（2021-2034年）

  • 国家
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太国家

第九章：中东和非洲生物防御市场分析、洞察与预测（2021-2034年）

  • 国家
    • 伊朗
    • 以色列
    • 沙乌地阿拉伯
    • 土耳其
    • 其他中东和非洲国家

第十章：拉丁美洲生物防御市场分析、洞察与预测（2021-2034年）

  • 国家
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家

第十一章 竞争分析

  • 全球市场排名分析（2025 年）
  • 竞争对手仪錶板

第十二章：公司简介

  • AirBoss Defense Group, Inc.（US）
  • Bioquell, An Ecolab Solution（US）
  • Bio-Rad Laboratories, Inc.（US）
  • BlueDot Inc.（Canada）
  • E4life Srl（Australia）
  • Emergent BioSolutions Inc.（US）
  • SIGA Technologies, Inc.（US）
  • Dynavax Technologies（US）
  • Alnylam Pharmaceuticals, Inc.（US）
  • Ichor Medical Systems Inc.（US）
  • Bavarian Nordic A/S（Denmark）
  • SKAN AG（Switzerland）
  • Smiths Detection Group Ltd（UK）
  • Parsons Corporation（US）
Product Code: FBI113684

Growth Factors of biodefense Market

The global biodefense market was valued at USD 16.23 billion in 2025 and is projected to grow to USD 17.75 billion in 2026, reaching USD 26.88 billion by 2034, registering a CAGR of 5.32% during the forecast period. In 2025, North America dominated the global market with a 42.97% share, driven by strong government investment, advanced healthcare infrastructure, and active participation from biotechnology and pharmaceutical companies.

Biodefense refers to a comprehensive system of strategies, technologies, and policies designed to protect populations, ecosystems, and national security from biological threats. These threats may arise from natural outbreaks, accidental releases, or deliberate biological attacks. Biodefense initiatives typically include vaccine development, pathogen detection systems, biosurveillance, and emergency response preparedness. The growing risks of pandemics, bioterrorism, and emerging infectious diseases are major factors accelerating investments in this sector.

Impact of the Russia-Ukraine Conflict

The ongoing Russia-Ukraine conflict has heightened global awareness of unconventional warfare risks, including the potential use of biological agents. This geopolitical situation has encouraged governments and defense organizations to strengthen biodefense capabilities and invest more heavily in biosurveillance, rapid diagnostics, and medical countermeasures.

The war has also exposed vulnerabilities in healthcare systems and supply chains, pushing nations to enhance domestic production of vaccines and protective equipment. Many countries have increased research funding for pathogen detection technologies and biosecurity infrastructure. Consequently, the conflict has indirectly accelerated biodefense spending, particularly in North America and Europe, as governments focus on strengthening pandemic preparedness and national security.

Market Dynamics

Market Drivers

Increasing Awareness of Biological Risks

Growing awareness of biological threats, combined with government initiatives, is driving biodefense market growth. Governments worldwide are investing heavily in vaccine stockpiling, pathogen detection systems, and advanced biosurveillance technologies. For example, in April 2025, Parsons Corporation received a USD 24 million contract from the Naval Medical Research Command to improve infectious disease detection research.

Technological innovations such as artificial intelligence (AI), machine learning, IoT-enabled biosensors, and rapid diagnostics are improving the speed and accuracy of biological threat detection. In addition, research breakthroughs-such as the nanopore-based biosensor developed at the University of Missouri in 2023-are advancing biosensor capabilities for early disease detection.

Market Restraints

High Development Costs and Regulatory Challenges

Despite strong demand, the biodefense market faces several challenges. Developing vaccines, diagnostics, and therapeutics for biological threats requires extensive research, clinical trials, and regulatory approvals, resulting in very high R&D costs.

Many biodefense products target rare diseases, making it difficult to conduct large clinical trials or demonstrate product effectiveness. Additionally, strict regulatory requirements and liability risks discourage some companies from investing in this sector. Without guaranteed government procurement contracts, companies may struggle to recover development costs.

Market Opportunities

Rising Biological Threats and Technological Advancements

The increasing occurrence of infectious diseases and pandemic threats presents significant growth opportunities. The COVID-19 pandemic demonstrated the importance of rapid detection systems and scalable vaccine production platforms.

Emerging technologies such as AI-powered biosurveillance, IoT-based biosensors, and genomic sequencing tools are creating new opportunities for early detection and response to biological threats. Furthermore, collaboration between governments, research institutions, and private companies is accelerating innovation and improving global preparedness against biological hazards.

Biodefense Market Trends

Integration of Advanced Technologies

Technological innovation is transforming biodefense capabilities. Artificial intelligence and machine learning are increasingly used for pathogen identification, outbreak prediction, and risk assessment.

For instance, TeselaGen Biotechnology partnered with BioMADE in 2022 to develop AI-driven data platforms that support fermentation-based biomanufacturing and biological threat response.

Additionally, advancements in biotechnology and genetic engineering are enabling the development of new vaccine platforms, rapid diagnostic tests, and advanced sterilization technologies. These innovations are expected to strengthen global biodefense infrastructure and improve preparedness against future biological emergencies.

Segmentation Analysis

By Technology

Based on technology, the market includes UV light, gamma radiation, cold plasma, microwave heating, and others.

The UV light segment accounted for the largest share in 2025 and is expected to be the fastest-growing segment. UV technology is widely used for sterilization and decontamination because it effectively inactivates microorganisms such as bacteria, viruses, and fungi. Increasing biosecurity awareness and demand for disinfection technologies after the COVID-19 pandemic are driving its growth.

By System

The market is categorized into digital biosurveillance networks, early warning systems, biohazard detection systems, AI-assisted surveillance systems, biosensors, and others.

The biohazard detection systems segment is projected to account for 35.19% of the market share in 2026, as these systems play a crucial role in identifying biological threats quickly. Meanwhile, the biosensors segment is expected to grow the fastest due to increasing demand for portable and highly sensitive pathogen detection devices.

By End User

The market is segmented into military forces, homeland security, hospitals & clinics, pharmaceutical & biotech companies, and virological research institutes.

The military forces segment is expected to dominate the market with a 36.61% share in 2026, as armed forces require advanced protective equipment, vaccines, and detection systems to safeguard personnel from biological threats.

The pharmaceutical & biotech companies segment is projected to be the fastest-growing due to rising investments in vaccine development, therapeutics, and diagnostic technologies.

Regional Outlook

North America

North America dominated the biodefense market in 2025, reaching USD 6.97 billion. The United States leads the regional market due to strong government initiatives and programs such as Project BioShield and BARDA. The U.S. market is projected to reach USD 7.41 billion by 2026.

Europe

Europe is expected to be the fastest-growing regional market due to increasing government funding for biosecurity and research programs. Countries such as the U.K. and Germany are investing heavily in biodefense technologies, with projected market sizes of USD 0.71 billion and USD 0.62 billion respectively by 2026.

Asia Pacific

Asia Pacific is witnessing strong growth due to rising public health concerns and increased investments in disease surveillance systems. By 2026, the market size is projected to reach USD 3.48 billion in China, USD 0.65 billion in India, and USD 0.44 billion in Japan.

Middle East & Africa and Latin America

These regions are expected to experience moderate growth due to increasing awareness of biological threats, government initiatives, and expanding biotechnology research activities.

Competitive Landscape

The biodefense market is highly competitive, with major players focusing on innovation, partnerships, and acquisitions to strengthen their positions. Key companies include AirBoss Defense Group, Emergent BioSolutions, SIGA Technologies, Bio Rad Laboratories, and Smiths Detection.

Recent developments include vaccine approvals, government procurement contracts, and collaborations aimed at strengthening global biological threat response capabilities.

Conclusion

The biodefense market is expected to grow steadily from USD 16.23 billion in 2025 to USD 26.88 billion by 2034, driven by rising concerns about pandemics, biological warfare, and emerging infectious diseases. Increasing government investments, technological innovations such as AI-based biosurveillance and advanced biosensors, and growing public-private collaborations are shaping the future of the industry.

While challenges such as high R&D costs and regulatory complexities remain, expanding global preparedness for biological threats will continue to drive demand for vaccines, detection systems, and biosurveillance technologies. North America will likely maintain its leadership, while Europe and Asia Pacific emerge as key growth regions in the coming decade.

By Segmentation By Technology

  • UV Light
  • Gamma Radiation
  • Cold Plasma
  • Microwave Heating
  • Others

By System

  • Digital Biosurveillance Networks
  • Early Warning Systems
  • Biohazard Detection Systems
  • AI-Assisted Surveillance System
  • Biosensors
  • Others

By End User

  • Military Forces
  • Homeland Security
  • Hospitals & Clinics
  • Pharmaceutical & Biotech Companies
  • Virological Research Institutes

By Region

  • North America (By Technology, By System, By End User, By Country)
    • U.S. (By End User)
    • Canada (By End User)
  • Europe (By Technology, By System, By End User, By Country)
    • U.K. (By End User)
    • Germany (By End User)
    • France (By End User)
    • Russia (By End User)
    • Rest of Europe (By End User)
  • Asia Pacific (By Technology, By System, By End User, By Country)
    • China (By End User)
    • India (By End User)
    • Japan (By End User)
    • South Korea (By End User)
    • Rest of Asia Pacific (By End User)
  • Middle East & Africa (By Technology, By System, By End User, By Country)
  • Iran (By End User)
    • Israel (By End User)
    • Saudi Arabia (By End User)
    • Turkey (By End User)
    • Rest of Middle East & Africa (By End User)
  • Latin America (By Technology, By System, By End User, By Country)
    • Brazil (By End User)
    • Argentina (By End User)
    • Mexico (By End User)
    • Rest of Latin America (By End User)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments - Key Contracts & Agreements, Mergers, Acquisitions and Partnerships
  • 4.2. Latest Technological Advancements
  • 4.3. Porters Five Forces Analysis
  • 4.4. Supply Chain Analysis
  • 4.5. Qualitative Insights - Impact of COVID-19 Pandemic on Global Biodefense Market
  • 4.6. Regulatory Analysis on Global Biodefense Market

5. Global Biodefense Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Definition
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Microwave Heating
    • 5.2.2. UV Light
    • 5.2.3. Gamma Radiation
    • 5.2.4. Cold Plasma
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By System
    • 5.3.1. Digital Biosurveillance Networks
    • 5.3.2. Early Warning Systems
    • 5.3.3. Biohazard Detection Systems
    • 5.3.4. AI-Assisted Surveillance System
    • 5.3.5. Biosensors
    • 5.3.6. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Military Forces
    • 5.4.2. Homeland Security
    • 5.4.3. Hospitals & Clinics
    • 5.4.4. Pharmaceutical & Biotech Companies
    • 5.4.5. Virological Research Institutes
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Middle East & Africa
    • 5.5.5. Latin America

6. North America Biodefense Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Microwave Heating
    • 6.1.2. UV Light
    • 6.1.3. Gamma Radiation
    • 6.1.4. Cold Plasma
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By System
    • 6.2.1. Digital Biosurveillance Networks
    • 6.2.2. Early Warning Systems
    • 6.2.3. Biohazard Detection Systems
    • 6.2.4. AI-Assisted Surveillance System
    • 6.2.5. Biosensors
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Military Forces
    • 6.3.2. Homeland Security
    • 6.3.3. Hospitals & Clinics
    • 6.3.4. Pharmaceutical & Biotech Companies
    • 6.3.5. Virological Research Institutes
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 6.4.1.1.1. Military Forces
        • 6.4.1.1.2. Homeland Security
        • 6.4.1.1.3. Hospitals & Clinics
        • 6.4.1.1.4. Pharmaceutical & Biotech Companies
        • 6.4.1.1.5. Virological Research Institutes
    • 6.4.2. Canada
      • 6.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 6.4.2.1.1. Military Forces
        • 6.4.2.1.2. Homeland Security
        • 6.4.2.1.3. Hospitals & Clinics
        • 6.4.2.1.4. Pharmaceutical & Biotech Companies
        • 6.4.2.1.5. Virological Research Institutes

7. Europe Biodefense Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Microwave Heating
    • 7.1.2. UV Light
    • 7.1.3. Gamma Radiation
    • 7.1.4. Cold Plasma
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By System
    • 7.2.1. Digital Biosurveillance Networks
    • 7.2.2. Early Warning Systems
    • 7.2.3. Biohazard Detection Systems
    • 7.2.4. AI-Assisted Surveillance System
    • 7.2.5. Biosensors
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Military Forces
    • 7.3.2. Homeland Security
    • 7.3.3. Hospitals & Clinics
    • 7.3.4. Pharmaceutical & Biotech Companies
    • 7.3.5. Virological Research Institutes
  • 7.4. Market Analysis, Insights and Forecast - By Country
    • 7.4.1. U.K.
      • 7.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.1.1.1. Military Forces
        • 7.4.1.1.2. Homeland Security
        • 7.4.1.1.3. Hospitals & Clinics
        • 7.4.1.1.4. Pharmaceutical & Biotech Companies
        • 7.4.1.1.5. Virological Research Institutes
    • 7.4.2. Germany
      • 7.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.2.1.1. Military Forces
        • 7.4.2.1.2. Homeland Security
        • 7.4.2.1.3. Hospitals & Clinics
        • 7.4.2.1.4. Pharmaceutical & Biotech Companies
        • 7.4.2.1.5. Virological Research Institutes
    • 7.4.3. France
      • 7.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.3.1.1. Military Forces
        • 7.4.3.1.2. Homeland Security
        • 7.4.3.1.3. Hospitals & Clinics
        • 7.4.3.1.4. Pharmaceutical & Biotech Companies
        • 7.4.3.1.5. Virological Research Institutes
    • 7.4.4. Russia
      • 7.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.4.1.1. Military Forces
        • 7.4.4.1.2. Homeland Security
        • 7.4.4.1.3. Hospitals & Clinics
        • 7.4.4.1.4. Pharmaceutical & Biotech Companies
        • 7.4.4.1.5. Virological Research Institutes
    • 7.4.5. Rest of Europe
      • 7.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.5.1.1. Military Forces
        • 7.4.5.1.2. Homeland Security
        • 7.4.5.1.3. Hospitals & Clinics
        • 7.4.5.1.4. Pharmaceutical & Biotech Companies
        • 7.4.5.1.5. Virological Research Institutes

8. Asia Pacific Biodefense Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Microwave Heating
    • 8.1.2. UV Light
    • 8.1.3. Gamma Radiation
    • 8.1.4. Cold Plasma
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By System
    • 8.2.1. Digital Biosurveillance Networks
    • 8.2.2. Early Warning Systems
    • 8.2.3. Biohazard Detection Systems
    • 8.2.4. AI-Assisted Surveillance System
    • 8.2.5. Biosensors
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Military Forces
    • 8.3.2. Homeland Security
    • 8.3.3. Hospitals & Clinics
    • 8.3.4. Pharmaceutical & Biotech Companies
    • 8.3.5. Virological Research Institutes
  • 8.4. Market Analysis, Insights and Forecast - By Country
    • 8.4.1. China
      • 8.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.1.1.1. Military Forces
        • 8.4.1.1.2. Homeland Security
        • 8.4.1.1.3. Hospitals & Clinics
        • 8.4.1.1.4. Pharmaceutical & Biotech Companies
        • 8.4.1.1.5. Virological Research Institutes
    • 8.4.2. India
      • 8.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.2.1.1. Military Forces
        • 8.4.2.1.2. Homeland Security
        • 8.4.2.1.3. Hospitals & Clinics
        • 8.4.2.1.4. Pharmaceutical & Biotech Companies
        • 8.4.2.1.5. Virological Research Institutes
    • 8.4.3. Japan
      • 8.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.3.1.1. Military Forces
        • 8.4.3.1.2. Homeland Security
        • 8.4.3.1.3. Hospitals & Clinics
        • 8.4.3.1.4. Pharmaceutical & Biotech Companies
        • 8.4.3.1.5. Virological Research Institutes
    • 8.4.4. South Korea
      • 8.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.4.1.1. Military Forces
        • 8.4.4.1.2. Homeland Security
        • 8.4.4.1.3. Hospitals & Clinics
        • 8.4.4.1.4. Pharmaceutical & Biotech Companies
        • 8.4.4.1.5. Virological Research Institutes
    • 8.4.5. Rest of Asia Pacific
      • 8.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.5.1.1. Military Forces
        • 8.4.5.1.2. Homeland Security
        • 8.4.5.1.3. Hospitals & Clinics
        • 8.4.5.1.4. Pharmaceutical & Biotech Companies
        • 8.4.5.1.5. Virological Research Institutes

9. Middle East & Africa Biodefense Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Microwave Heating
    • 9.1.2. UV Light
    • 9.1.3. Gamma Radiation
    • 9.1.4. Cold Plasma
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By System
    • 9.2.1. Digital Biosurveillance Networks
    • 9.2.2. Early Warning Systems
    • 9.2.3. Biohazard Detection Systems
    • 9.2.4. AI-Assisted Surveillance System
    • 9.2.5. Biosensors
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Military Forces
    • 9.3.2. Homeland Security
    • 9.3.3. Hospitals & Clinics
    • 9.3.4. Pharmaceutical & Biotech Companies
    • 9.3.5. Virological Research Institutes
  • 9.4. Market Analysis, Insights and Forecast - By Country
    • 9.4.1. Iran
      • 9.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.1.1.1. Military Forces
        • 9.4.1.1.2. Homeland Security
        • 9.4.1.1.3. Hospitals & Clinics
        • 9.4.1.1.4. Pharmaceutical & Biotech Companies
        • 9.4.1.1.5. Virological Research Institutes
    • 9.4.2. Israel
      • 9.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.2.1.1. Military Forces
        • 9.4.2.1.2. Homeland Security
        • 9.4.2.1.3. Hospitals & Clinics
        • 9.4.2.1.4. Pharmaceutical & Biotech Companies
        • 9.4.2.1.5. Virological Research Institutes
    • 9.4.3. Saudi Arabia
      • 9.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.3.1.1. Military Forces
        • 9.4.3.1.2. Homeland Security
        • 9.4.3.1.3. Hospitals & Clinics
        • 9.4.3.1.4. Pharmaceutical & Biotech Companies
        • 9.4.3.1.5. Virological Research Institutes
    • 9.4.4. Turkey
      • 9.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.4.1.1. Military Forces
        • 9.4.4.1.2. Homeland Security
        • 9.4.4.1.3. Hospitals & Clinics
        • 9.4.4.1.4. Pharmaceutical & Biotech Companies
        • 9.4.4.1.5. Virological Research Institutes
    • 9.4.5. Rest of Middle East & Africa
      • 9.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.5.1.1. Military Forces
        • 9.4.5.1.2. Homeland Security
        • 9.4.5.1.3. Hospitals & Clinics
        • 9.4.5.1.4. Pharmaceutical & Biotech Companies
        • 9.4.5.1.5. Virological Research Institutes

10. Latin America Biodefense Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Microwave Heating
    • 10.1.2. UV Light
    • 10.1.3. Gamma Radiation
    • 10.1.4. Cold Plasma
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By System
    • 10.2.1. Digital Biosurveillance Networks
    • 10.2.2. Early Warning Systems
    • 10.2.3. Biohazard Detection Systems
    • 10.2.4. AI-Assisted Surveillance System
    • 10.2.5. Biosensors
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Military Forces
    • 10.3.2. Homeland Security
    • 10.3.3. Hospitals & Clinics
    • 10.3.4. Pharmaceutical & Biotech Companies
    • 10.3.5. Virological Research Institutes
  • 10.4. Market Analysis, Insights and Forecast - By Country
    • 10.4.1. Brazil
      • 10.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.1.1.1. Military Forces
        • 10.4.1.1.2. Homeland Security
        • 10.4.1.1.3. Hospitals & Clinics
        • 10.4.1.1.4. Pharmaceutical & Biotech Companies
        • 10.4.1.1.5. Virological Research Institutes
    • 10.4.2. Argentina
      • 10.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.2.1.1. Military Forces
        • 10.4.2.1.2. Homeland Security
        • 10.4.2.1.3. Hospitals & Clinics
        • 10.4.2.1.4. Pharmaceutical & Biotech Companies
        • 10.4.2.1.5. Virological Research Institutes
    • 10.4.3. Mexico
      • 10.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.3.1.1. Military Forces
        • 10.4.3.1.2. Homeland Security
        • 10.4.3.1.3. Hospitals & Clinics
        • 10.4.3.1.4. Pharmaceutical & Biotech Companies
        • 10.4.3.1.5. Virological Research Institutes
    • 10.4.4. Rest of Latin America
      • 10.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.4.1.1. Military Forces
        • 10.4.4.1.2. Homeland Security
        • 10.4.4.1.3. Hospitals & Clinics
        • 10.4.4.1.4. Pharmaceutical & Biotech Companies
        • 10.4.4.1.5. Virological Research Institutes

11. Competitive Analysis

  • 11.1. Global Market Rank Analysis (2025)
  • 11.2. Competitive Dashboard

12. Company Profiles

  • 12.1. AirBoss Defense Group, Inc. (U.S.)
    • 12.1.1. Overview
    • 12.1.2. Products & services
    • 12.1.3. SWOT Analysis
    • 12.1.4. Recent Developments
    • 12.1.5. Strategies
    • 12.1.6. Financials (Based on Availability)
  • 12.2. Bioquell, An Ecolab Solution (U.S.)
    • 12.2.1. Overview
    • 12.2.2. Products & services
    • 12.2.3. SWOT Analysis
    • 12.2.4. Recent Developments
    • 12.2.5. Strategies
    • 12.2.6. Financials (Based on Availability)
  • 12.3. Bio-Rad Laboratories, Inc. (U.S.)
    • 12.3.1. Overview
    • 12.3.2. Products & services
    • 12.3.3. SWOT Analysis
    • 12.3.4. Recent Developments
    • 12.3.5. Strategies
    • 12.3.6. Financials (Based on Availability)
  • 12.4. BlueDot Inc. (Canada)
    • 12.4.1. Overview
    • 12.4.2. Products & services
    • 12.4.3. SWOT Analysis
    • 12.4.4. Recent Developments
    • 12.4.5. Strategies
    • 12.4.6. Financials (Based on Availability)
  • 12.5. E4life Srl (Australia)
    • 12.5.1. Overview
    • 12.5.2. Products & services
    • 12.5.3. SWOT Analysis
    • 12.5.4. Recent Developments
    • 12.5.5. Strategies
    • 12.5.6. Financials (Based on Availability)
  • 12.6. Emergent BioSolutions Inc. (U.S.)
    • 12.6.1. Overview
    • 12.6.2. Products & services
    • 12.6.3. SWOT Analysis
    • 12.6.4. Recent Developments
    • 12.6.5. Strategies
    • 12.6.6. Financials (Based on Availability)
  • 12.7. SIGA Technologies, Inc. (U.S.)
    • 12.7.1. Overview
    • 12.7.2. Products & services
    • 12.7.3. SWOT Analysis
    • 12.7.4. Recent Developments
    • 12.7.5. Strategies
    • 12.7.6. Financials (Based on Availability)
  • 12.8. Dynavax Technologies (U.S.)
    • 12.8.1. Overview
    • 12.8.2. Products & services
    • 12.8.3. SWOT Analysis
    • 12.8.4. Recent Developments
    • 12.8.5. Strategies
    • 12.8.6. Financials (Based on Availability)
  • 12.9. Alnylam Pharmaceuticals, Inc. (U.S.)
    • 12.9.1. Overview
    • 12.9.2. Products & services
    • 12.9.3. SWOT Analysis
    • 12.9.4. Recent Developments
    • 12.9.5. Strategies
    • 12.9.6. Financials (Based on Availability)
  • 12.10. Ichor Medical Systems Inc. (U.S.)
    • 12.10.1. Overview
    • 12.10.2. Products & services
    • 12.10.3. SWOT Analysis
    • 12.10.4. Recent Developments
    • 12.10.5. Strategies
    • 12.10.6. Financials (Based on Availability)
  • 12.11. Bavarian Nordic A/S (Denmark)
    • 12.11.1. Overview
    • 12.11.2. Products & services
    • 12.11.3. SWOT Analysis
    • 12.11.4. Recent Developments
    • 12.11.5. Strategies
    • 12.11.6. Financials (Based on Availability)
  • 12.12. SKAN AG (Switzerland)
    • 12.12.1. Overview
    • 12.12.2. Products & services
    • 12.12.3. SWOT Analysis
    • 12.12.4. Recent Developments
    • 12.12.5. Strategies
    • 12.12.6. Financials (Based on Availability)
  • 12.13. Smiths Detection Group Ltd (U.K.)
    • 12.13.1. Overview
    • 12.13.2. Products & services
    • 12.13.3. SWOT Analysis
    • 12.13.4. Recent Developments
    • 12.13.5. Strategies
    • 12.13.6. Financials (Based on Availability)
  • 12.14. Parsons Corporation (U.S.)
    • 12.14.1. Overview
    • 12.14.2. Products & services
    • 12.14.3. SWOT Analysis
    • 12.14.4. Recent Developments
    • 12.14.5. Strategies
    • 12.14.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Biodefense Market, (USD Bn) Forecast, By Technology, 2021-2034
  • Table 2: Global Biodefense Market, (USD Bn) Forecast, By System, 2021-2034
  • Table 3: Global Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 4: Global Biodefense Market (USD Bn) Forecast, By Region, 2021-2034
  • Table 5: North America Biodefense Market, (USD Bn) Forecast, By Technology, 2021-2034
  • Table 6: North America Biodefense Market, (USD Bn) Forecast, By System, 2021-2034
  • Table 7: North America Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 8: North America Biodefense Market (USD Bn) Forecast, By Country, 2021-2034
  • Table 9: U.S. Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 10: Canada Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 11: Europe Biodefense Market, (USD Bn) Forecast, By Technology, 2021-2034
  • Table 12: Europe Biodefense Market, (USD Bn) Forecast, By System, 2021-2034
  • Table 13: Europe Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 14: Europe Biodefense Market (USD Bn) Forecast, By Country, 2021-2034
  • Table 15: U.K. Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 16: Germany Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 17: France Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 18: Russia Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 19: Rest of Europe Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Biodefense Market, (USD Bn) Forecast, By Technology, 2021-2034
  • Table 21: Asia Pacific Biodefense Market, (USD Bn) Forecast, By System, 2021-2034
  • Table 22: Asia Pacific Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 23: Asia Pacific Biodefense Market (USD Bn) Forecast, By Country, 2021-2034
  • Table 24: China Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 25: India Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 26: Japan Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 27: South Korea Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 28: Rest of Asia Pacific Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 29: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By Technology, 2021-2034
  • Table 30: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By System, 2021-2034
  • Table 31: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 32: Middle East & Africa Biodefense Market (USD Bn) Forecast, By Country, 2021-2034
  • Table 33: Iran Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 34: Israel Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 35: Saudi Arabia Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 36: Turkey Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 37: Rest of Middle East & Africa Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 38: Latin America Biodefense Market, (USD Bn) Forecast, By Technology, 2021-2034
  • Table 39: Latin America Biodefense Market, (USD Bn) Forecast, By System, 2021-2034
  • Table 40: Latin America Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 41: Latin America Biodefense Market (USD Bn) Forecast, By Country, 2021-2034
  • Table 42: Brazil Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 43: Argentina Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 44: Mexico Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034
  • Table 45: Rest of Latin America Biodefense Market, (USD Bn) Forecast, By End User, 2021-2034

List of Figures

  • Figure 1: Global Biodefense Market Revenue Breakdown (USD Billion, %) By Region, 2025 & 2034
  • Figure 2: Global Biodefense Market (%) Breakdown By Technology, 2025 & 2034
  • Figure 3: Global Biodefense Market (USD Bn) Breakdown By Microwave Heating, 2021-2034
  • Figure 4: Global Biodefense Market (USD Bn) Breakdown By UV Light, 2021-2034
  • Figure 5: Global Biodefense Market (USD Bn) Breakdown By Gamma Radiation, 2021-2034
  • Figure 6: Global Biodefense Market (USD Bn) Breakdown By Cold Plasma, 2021-2034
  • Figure 7: Global Biodefense Market (USD Bn) Breakdown By Others, 2021-2034
  • Figure 8: Global Biodefense Market (%) Breakdown By System, 2025 & 2034
  • Figure 9: Global Biodefense Market (USD Bn) Breakdown By Digital Biosurveillance Networks, 2021-2034
  • Figure 10: Global Biodefense Market (USD Bn) Breakdown By Early Warning Systems, 2021-2034
  • Figure 11: Global Biodefense Market (USD Bn) Breakdown By Biohazard Detection Systems, 2021-2034
  • Figure 12: Global Biodefense Market (USD Bn) Breakdown By AI-Assisted Surveillance System, 2021-2034
  • Figure 13: Global Biodefense Market (USD Bn) Breakdown By Biosensors, 2021-2034
  • Figure 14: Global Biodefense Market (USD Bn) Breakdown By Others, 2021-2034
  • Figure 15: Global Biodefense Market (%) Breakdown By End User, 2025 & 2034
  • Figure 16: Global Biodefense Market (USD Bn) Breakdown By Military Forces, 2021-2034
  • Figure 17: Global Biodefense Market (USD Bn) Breakdown By Homeland Security, 2021-2034
  • Figure 18: Global Biodefense Market (USD Bn) Breakdown By Hospitals & Clinics, 2021-2034
  • Figure 19: Global Biodefense Market (USD Bn) Breakdown By Pharmaceutical & Biotech Companies, 2021-2034
  • Figure 20: Global Biodefense Market (USD Bn) Breakdown By Virological Research Institutes, 2021-2034
  • Figure 21: Global Biodefense Market Share (%) By Region, 2025 & 2034
  • Figure 22: North America Biodefense Market Value (USD Bn) By Technology, 2025 & 2034
  • Figure 23: North America Biodefense Market Value Share (%) By Technology, 2025
  • Figure 24: North America Biodefense Market Value (USD Bn) By System, 2025 & 2034
  • Figure 25: North America Biodefense Market Value Share (%) By System, 2025
  • Figure 26: North America Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 27: North America Biodefense Market Value Share (%) By End User, 2025
  • Figure 28: North America Biodefense Market Value (USD Bn) By Country, 2025 & 2034
  • Figure 29: North America Biodefense Value Share (%) By Country, 2025
  • Figure 30: U.S. Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 31: U.S. Biodefense Market Value Share (%) By End User, 2025
  • Figure 32: Canada Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 33: Canada Biodefense Market Value Share (%) By End User, 2025
  • Figure 34: Europe Biodefense Market Value (USD Bn) By Technology, 2025 & 2034
  • Figure 35: Europe Biodefense Market Value Share (%) By Technology, 2025
  • Figure 36: Europe Biodefense Market Value (USD Bn) By System, 2025 & 2034
  • Figure 37: Europe Biodefense Market Value Share (%) By System, 2025
  • Figure 38: Europe Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 39: Europe Biodefense Market Value Share (%) By End User, 2025
  • Figure 40: Europe Biodefense Market Value (USD Bn) By Country, 2025 & 2034
  • Figure 41: Europe Biodefense Value Share (%) By Country, 2025
  • Figure 42: U.K. Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 43: U.K. Biodefense Market Value Share (%) By End User, 2025
  • Figure 44: Germany Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 45: Germany Biodefense Market Value Share (%) By End User, 2025
  • Figure 46: France Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 47: France Biodefense Market Value Share (%) By End User, 2025
  • Figure 48: Russia Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 49: Russia Biodefense Market Value Share (%) By End User, 2025
  • Figure 50: Rest of Europe Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 51: Rest of Europe Biodefense Market Value Share (%) By End User, 2025
  • Figure 52: Asia Pacific Biodefense Market Value (USD Bn) By Technology, 2025 & 2034
  • Figure 53: Asia Pacific Biodefense Market Value Share (%) By Technology, 2025
  • Figure 54: Asia Pacific Biodefense Market Value (USD Bn) By System, 2025 & 2034
  • Figure 55: Asia Pacific Biodefense Market Value Share (%) By System, 2025
  • Figure 56: Asia Pacific Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 57: Asia Pacific Biodefense Market Value Share (%) By End User, 2025
  • Figure 58: Asia Pacific Biodefense Market Value (USD Bn) By Country, 2025 & 2034
  • Figure 59: Asia Pacific Biodefense Value Share (%) By Country, 2025
  • Figure 60: China Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 61: China Biodefense Market Value Share (%) By End User, 2025
  • Figure 62: India Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 63: India Biodefense Market Value Share (%) By End User, 2025
  • Figure 64: Japan Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 65: Japan Biodefense Market Value Share (%) By End User, 2025
  • Figure 66: South Korea Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 67: South Korea Biodefense Market Value Share (%) By End User, 2025
  • Figure 68: Rest of Asia Pacific Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 69: Rest of Asia Pacific Biodefense Market Value Share (%) By End User, 2025
  • Figure 70: Middle East & Africa Biodefense Market Value (USD Bn) By Technology, 2025 & 2034
  • Figure 71: Middle East & Africa Biodefense Market Value Share (%) By Technology, 2025
  • Figure 72: Middle East & Africa Biodefense Market Value (USD Bn) By System, 2025 & 2034
  • Figure 73: Middle East & Africa Biodefense Market Value Share (%) By System, 2025
  • Figure 74: Middle East & Africa Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 75: Middle East & Africa Biodefense Market Value Share (%) By End User, 2025
  • Figure 76: Middle East & Africa Biodefense Market Value (USD Bn) By Country, 2025 & 2034
  • Figure 77: Middle East & Africa Biodefense Value Share (%) By Country, 2025
  • Figure 78: Iran Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 79: Iran Biodefense Market Value Share (%) By End User, 2025
  • Figure 80: Israel Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 81: Israel Biodefense Market Value Share (%) By End User, 2025
  • Figure 82: Saudi Arabia Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 83: Saudi Arabia Biodefense Market Value Share (%) By End User, 2025
  • Figure 84: Turkey Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 85: Turkey Biodefense Market Value Share (%) By End User, 2025
  • Figure 86: Rest of Middle East & Africa Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 87: Rest of Middle East & Africa Biodefense Market Value Share (%) By End User, 2025
  • Figure 88: Latin America Biodefense Market Value (USD Bn) By Technology, 2025 & 2034
  • Figure 89: Latin America Biodefense Market Value Share (%) By Technology, 2025
  • Figure 90: Latin America Biodefense Market Value (USD Bn) By System, 2025 & 2034
  • Figure 91: Latin America Biodefense Market Value Share (%) By System, 2025
  • Figure 92: Latin America Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 93: Latin America Biodefense Market Value Share (%) By End User, 2025
  • Figure 94: Latin America Biodefense Market Value (USD Bn) By Country, 2025 & 2034
  • Figure 95: Latin America Biodefense Value Share (%) By Country, 2025
  • Figure 96: Brazil Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 97: Brazil Biodefense Market Value Share (%) By End User, 2025
  • Figure 98: Argentina Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 99: Argentina Biodefense Market Value Share (%) By End User, 2025
  • Figure 100: Mexico Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 101: Mexico Biodefense Market Value Share (%) By End User, 2025
  • Figure 102: Rest of Latin America Biodefense Market Value (USD Bn) By End User, 2025 & 2034
  • Figure 103: Rest of Latin America Biodefense Market Value Share (%) By End User, 2025
  • Figure 104: Global Biodefense Market Rank Analysis, By Key Players, 2025